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Acute intermittent porphyria (AIP) is autosomal dominant disorder caused by the partial 
deficiency of porphobilinogen deaminase (PBGD), the third enzyme in the heme biosynthetic 
pathway. AIP is manifested by life-threatening acute neurological attacks that can be 
provoked by various factors such as drugs or alcohol. 
 
 
Objective of this study was to identify and characterize the molecular lesions in Czech and 
Slovak AIP patients. To identify disease-causing mutations screening was performed by PCR, 
denaturing gradient gel electrophoresis (DGGE), automated DNA sequencing and restriction 
fragment lenght polymorphism (RFLP) assays. Total of 35 individuals from 8 families were 
analyzed to detect asymptomatic carriers. Seven mutations were identified, including 3 novel 
mutations. Of particular interest, one patient had two mutations R173Q and Q204K, both 
located in exon 10 on the same allele. To further characterize these mutations, human PBGD 
was cloned into the pGEX-4T-1 vector and mutations were generated by site-directed 
mutagenesis. The wild-type and mutated enzyme species were expressed in E. coli as GST 
fusions and purified by affinity chromatography. Conditions of the PBGD enzyme assay were 
determined and specific activities, thermostability and pH optima of mutated enzymes were 
measured and compared to the wild-type protein. R173Q was the causative mutation with 
major effect on the PBGD function. The Q204K mutated PBGD had high residual activity but 
thermostability was decreased by 75%. pH optimum for Q204K mutated protein was the same 
as for the wild-type. 
 
 
To conclude, three novel mutations were identified in AIP patients. These studies provide 
accurate detection of asymptomatic carriers and emphasize the molecular heterogeneity of 
AIP. An unusual case of AIP with two mutations both located in 10. exon of the PBGD gene 
was characterized at molecular and enzymatic level. 
